Nao Kawaguchi

Also affiliated with Takatsuki General Hospital, Futaba (Japan), Osaka University of Pharmaceutical Sciences

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “Liver injury in COVID-19 and IL-6 trans-signaling-induced endotheliopathy”.

Liver injury in COVID-19 and IL-6 trans-signaling-induced endotheliopathy

Journal of Hepatology(2021)10.1016/j.jhep.2021.04.050

N/A

0DataRank · unranked

102 citations

Nao Kawaguchi, Reiichiro Kondo, Aurelio Sonzogni, Lisa Licini, Clarissa Valle +20 more

Covid‐19 and Liver Injury: Role of Inflammatory Endotheliopathy, Platelet Dysfunction, and Thrombosis

Hepatology Communications(2021)10.1002/hep4.1843

N/A

0DataRank · unranked

65 citations

Reiichiro Kondo, Nao Kawaguchi, Yasuko Iwakiri, Matthew J. McConnell

ASO Author Reflections: Predictors of Immune Checkpoint Inhibitor Response in ER+/HER2– Breast Cancer: A New Role for ESR1?

Annals of Surgical Oncology(2025)10.1245/s10434-025-18377-4

N/A

0DataRank · unranked

0 citations

Kohei Chida, Rongrong Wu, Kohei Taniguchi, Amber McKenery, Brian Morreale +17 more